Hostname: page-component-6766d58669-7fx5l Total loading time: 0 Render date: 2026-05-16T03:36:39.330Z Has data issue: false hasContentIssue false

Surgical and functional outcomes of two types of transcutaneous bone conduction implants

Published online by Cambridge University Press:  18 December 2020

G Scotta*
Affiliation:
Regional Department of Neurotology, Sheffield Teaching Hospital NHS Foundation Trust, UK
A Allam
Affiliation:
Regional Department of Neurotology, Sheffield Teaching Hospital NHS Foundation Trust, UK Department of ENT, Mansoura University, Egypt
P A Dimitriadis
Affiliation:
Regional Department of Neurotology, Sheffield Teaching Hospital NHS Foundation Trust, UK
K Wright
Affiliation:
Regional Department of Neurotology, Sheffield Teaching Hospital NHS Foundation Trust, UK
M Yardley
Affiliation:
Regional Department of Neurotology, Sheffield Teaching Hospital NHS Foundation Trust, UK
J Ray
Affiliation:
Regional Department of Neurotology, Sheffield Teaching Hospital NHS Foundation Trust, UK
*
Author for correspondence: Mr Gianluca Scotta, Regional Department of Neurotology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK E-mail: gianluca.scotta@gmail.com

Abstract

Objective

This study aimed to evaluate surgical and functional outcomes, in a tertiary referral centre, of two different types of semi-implantable transcutaneous bone conduction devices.

Method

This study involved prospective data collection and review of patients implanted between November 2014 and December 2016. Glasgow Hearing Aid Inventory (Glasgow Hearing Aid Benefit Profile or Glasgow Hearing Aid Difference Profile) and Client Oriented Scale of Improvement were completed where appropriate. Surgical and audiological outcomes were recorded in the surgical notes.

Results

Glasgow Hearing Aid Difference Profile and Glasgow Hearing Aid Benefit Profile showed similar mean score in the active and the passive transcutaneous bone conduction devices. Client Oriented Scale of Improvement showed improvements in listening situations. Post-operative speech reception threshold showed better mean threshold in the active transcutaneous bone conduction devices group when compared with the passive transcutaneous bone conduction devices group. No device failures or surgical complications existed in either group, with the surgical time being less in the passive transcutaneous bone conduction devices group.

Conclusion

Both devices are reliable semi-implantable transcutaneous bone conduction devices with excellent surgical and functional outcomes and patient satisfaction. Overall surgical time was much less in the passive transcutaneous bone conduction devices group with no necessity for pre-planning. This is much easier to remove with the possibility of conversion to other devices in the manufacturer’s portfolio and wide-ranging wireless accessories. Further studies are needed to assess the longer-term results in a bigger population.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited, 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable